Coldstream Laboratories Announces Manager of Technology Transfer
Sholto Maclean Named Manager of Technology Transfer at Coldstream Labs
(firmenpresse) - LEXINGTON, KY -- (Marketwire) -- 01/23/12 -- , a provider of drug product research and manufacturing services specializing in high potency and cytotoxic parenteral products, has named Sholto Maclean as Manager of Technology Transfer.
In the newly created position, Maclean will work closely with Coldstream's pharmaceutical development team to scale up processes for sterile liquid and lyophilized drug products for manufacturing in the company's sterile manufacturing facility.
Maclean brings to Coldstream over 20 years of experience in parenteral processing, sterile product development, lyophilization development and aseptic manufacturing. Most recently, he served as a lyophilization/technology transfer consultant for a major pharmaceutical company. Past experience includes positions at GlaxoSmithKline and DSM Pharmaceuticals.
"We are pleased to announce the addition of Mr. Maclean to Coldstream's management team," said Coldstream President and CEO Larry Kranking. "With his expertise in lyophilization, he is an ideal fit for our newly created technology transfer function. His in-depth experience will significantly enhance our team and provide Coldstream's clients with a wealth of knowledge specific to the development and manufacture of parenteral drugs."
Coldstream Laboratories, Inc. is a specialty manufacturer of sterile injectable drugs and operates Kentucky's only sterile pharmaceutical manufacturing facility.
For more information, visit
Coldstream Laboratories
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 23.01.2012 - 13:00 Uhr
Sprache: Deutsch
News-ID 1075517
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
LEXINGTON, KY
Phone:
Kategorie:
Drugs
Anmerkungen:
Diese Pressemitteilung wurde bisher 117 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Coldstream Laboratories Announces Manager of Technology Transfer
"
steht unter der journalistisch-redaktionellen Verantwortung von
Coldstream Laboratories (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
